Cargando…
Could Polyphenols Really Be a Good Radioprotective Strategy?
Currently, radiotherapy is one of the most effective strategies to treat cancer. However, deleterious toxicity against normal cells indicate for the need to selectively protect them. Reactive oxygen and nitrogen species reinforce ionizing radiation cytotoxicity, and compounds able to scavenge these...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398122/ https://www.ncbi.nlm.nih.gov/pubmed/34443561 http://dx.doi.org/10.3390/molecules26164969 |
_version_ | 1783744762451329024 |
---|---|
author | Faramarzi, Shadab Piccolella, Simona Manti, Lorenzo Pacifico, Severina |
author_facet | Faramarzi, Shadab Piccolella, Simona Manti, Lorenzo Pacifico, Severina |
author_sort | Faramarzi, Shadab |
collection | PubMed |
description | Currently, radiotherapy is one of the most effective strategies to treat cancer. However, deleterious toxicity against normal cells indicate for the need to selectively protect them. Reactive oxygen and nitrogen species reinforce ionizing radiation cytotoxicity, and compounds able to scavenge these species or enhance antioxidant enzymes (e.g., superoxide dismutase, catalase, and glutathione peroxidase) should be properly investigated. Antioxidant plant-derived compounds, such as phenols and polyphenols, could represent a valuable alternative to synthetic compounds to be used as radio-protective agents. In fact, their dose-dependent antioxidant/pro-oxidant efficacy could provide a high degree of protection to normal tissues, with little or no protection to tumor cells. The present review provides an update of the current scientific knowledge of polyphenols in pure forms or in plant extracts with good evidence concerning their possible radiomodulating action. Indeed, with few exceptions, to date, the fragmentary data available mostly derive from in vitro studies, which do not find comfort in preclinical and/or clinical studies. On the contrary, when preclinical studies are reported, especially regarding the bioactivity of a plant extract, its chemical composition is not taken into account, avoiding any standardization and compromising data reproducibility. |
format | Online Article Text |
id | pubmed-8398122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83981222021-08-29 Could Polyphenols Really Be a Good Radioprotective Strategy? Faramarzi, Shadab Piccolella, Simona Manti, Lorenzo Pacifico, Severina Molecules Review Currently, radiotherapy is one of the most effective strategies to treat cancer. However, deleterious toxicity against normal cells indicate for the need to selectively protect them. Reactive oxygen and nitrogen species reinforce ionizing radiation cytotoxicity, and compounds able to scavenge these species or enhance antioxidant enzymes (e.g., superoxide dismutase, catalase, and glutathione peroxidase) should be properly investigated. Antioxidant plant-derived compounds, such as phenols and polyphenols, could represent a valuable alternative to synthetic compounds to be used as radio-protective agents. In fact, their dose-dependent antioxidant/pro-oxidant efficacy could provide a high degree of protection to normal tissues, with little or no protection to tumor cells. The present review provides an update of the current scientific knowledge of polyphenols in pure forms or in plant extracts with good evidence concerning their possible radiomodulating action. Indeed, with few exceptions, to date, the fragmentary data available mostly derive from in vitro studies, which do not find comfort in preclinical and/or clinical studies. On the contrary, when preclinical studies are reported, especially regarding the bioactivity of a plant extract, its chemical composition is not taken into account, avoiding any standardization and compromising data reproducibility. MDPI 2021-08-17 /pmc/articles/PMC8398122/ /pubmed/34443561 http://dx.doi.org/10.3390/molecules26164969 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Faramarzi, Shadab Piccolella, Simona Manti, Lorenzo Pacifico, Severina Could Polyphenols Really Be a Good Radioprotective Strategy? |
title | Could Polyphenols Really Be a Good Radioprotective Strategy? |
title_full | Could Polyphenols Really Be a Good Radioprotective Strategy? |
title_fullStr | Could Polyphenols Really Be a Good Radioprotective Strategy? |
title_full_unstemmed | Could Polyphenols Really Be a Good Radioprotective Strategy? |
title_short | Could Polyphenols Really Be a Good Radioprotective Strategy? |
title_sort | could polyphenols really be a good radioprotective strategy? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398122/ https://www.ncbi.nlm.nih.gov/pubmed/34443561 http://dx.doi.org/10.3390/molecules26164969 |
work_keys_str_mv | AT faramarzishadab couldpolyphenolsreallybeagoodradioprotectivestrategy AT piccolellasimona couldpolyphenolsreallybeagoodradioprotectivestrategy AT mantilorenzo couldpolyphenolsreallybeagoodradioprotectivestrategy AT pacificoseverina couldpolyphenolsreallybeagoodradioprotectivestrategy |